The global CryopreservationEquipment Market, by Equipment (Freezers (Cryopreservation Freezers,Drystore Freezers), Incubators, Sample Preparation System, and Accessories), byCryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application(Cord Blood Stem Cells, Sperms, Semen & Testicular Tissues, Embryos &Oocytes, Other Application), by End User (Stem Cells Banks, Biotechnology andPharmaceutical organizations, Contract Research Organizations, Stem CellResearch Laboratories, and Research and Academic Institutes), and by Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$4.318.1 million in 2017 and is projected to exhibit a CAGR of 13.2% over theforecast period (2017–2025).
Cryopreservation equipment areused to cryopreserve biological samples by preventing the dehydration andformation of intracellular ice crystals. Cryopreservation equipment includescontrolled rate freezers, freezing racks and holders, cryogenic incubators,cryopreservation loading chambers and tanks, thermocouple sensor for temperatedetection, storage sample chambers, vapor and liquid phase storage, andcanister and cane systems.
Moreover, the increasing demandfor fertility treatment such as in-vitro fertilization (IVF) treatment andtherapies for women and higher effectiveness of frozen embryos in the IVFprocedures are expected to drive growth of the cryopreservation equipmentmarket. For instance, research findings published in the TIME Health, inJanuary 2018, conducted a study including 3,000 women in Vietnam who underwentIVF procedures, and were randomly assigned to receive frozen or fresh embryo.36% of the women implanted with frozen embryo had live births, as compared tothe 31% of them who were implanted with fresh embryo. Additionally, researchersat the Penn State College of Medicine, conducted a five-week study on womensuffering from polycystic ovarian syndrome (PCOS). Those who received frozenembryos during the in-vitro fertilization recorded safer and more successfulpregnancies than those who received fresh embryos. Frozen embryos lowered therisk of ovarian hyperstimulation syndrome by 7.1% to 10.3%, as compared tousing fresh embryos. Freezing embryos offers couples the advantage of genetictesting, to reduce the chance of the genetic diseases prior implantation of theembryo.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1356
The umbilical cord blood (UCB)stem cells is non-invasive alternative source of hematopoietic stem cells totreat a variety of blood and bone marrow diseases, blood cancers, metabolicdisorders, and immune deficiencies. Umbilical cord blood is required to becollected at the time of birth and be cryopreserved for future applications.However, low awareness regarding the benefits of preserving umbilical cordbanking (UCB), limits its application in the long run, thereby limiting growthof the cryopreservation equipment market.
A study published as the BankingUmbilical Cord Blood (UCB) Stem Cells: awareness, attitude and expectations ofdonor, in the National Center for Biotechnology Information (NCBI), in May2016, showed that pregnant women in emerging economies show lower awarenessregarding UCB. The study was conducted on 300 women, among whom only 26.5% wereaware of UCB, 31% were aware of the private cord blood banking, while only 16%were aware of public cord blood banking.
Browse 43 Market Data Tables and48 Figures spread through 180 Pages and in-depth TOC on “CryopreservationEquipment Market by Equipment (Freezers (Cryopreservation Freezers, DrystoreFreezers), Incubators, Sample Preparation System, and Accessories), by Cryogen(Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application (Cord BloodStem Cells, Sperms, Semen & Testicular Tissues, Embryos & Oocytes,Other Application), by End User (Stem Cells Banks, Biotechnology andPharmaceutical organizations, Contract Research Organizations, Stem CellResearch Laboratories, and Research and Academic Institutes), and by Region (North America,Latin America, Europe, Asia Pacific, Middle East, and Africa)” - GlobalForecast to 2025
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/cryopreservation-equipment-market-1356
Key Takeaways of theCryopreservation Equipment Market:
The global cryopreservationequipment market is expected to exhibit a CAGR of 13.2% over the forecastperiod, owing to increasing numbers IVF procedures
Among equipment, the freezerssegment is estimated to hold a dominant position in the market in 2017, as thefreezers are an inevitable equipment used in most of the cryopreservationprocedures.
Among cryogen, the liquidnitrogen segment holds a dominant position, owing to the increasing adaptationof liquid nitrogen for preserving biological samples in vapor and liquid phasesfor longer periods of time
Among applications, the cordblood stem cells segment is the largest segment, owing to increasing number ofpatients undergoing IVF procedures
Among end users, the stem cellresearch laboratory segment holds a dominant position in the market, owing toincreasing application of stem cells in the treatment of various diseases, suchas leukemia, hematopoietic disorders, and autoimmune disease.
Some of the key players operatingin the cryopreservation equipment market are Thermo Fisher Scientific, Inc.,Custom Biogenic Systems, Chart Biomedical Co. Ltd., Merck KGaA, Barber-NicholsInc., Praxair Technology, Inc., Linde LLC, Planer PLC, Cryologic Pty. Ltd.,Charter Medicals, Nikkiso Cryo Inc., Cryogenic Control, and Haimen UnitedLaboratory Equipment Development Co., Ltd.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/1356
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
